Clinical Trial Update: Registry for Patients With Erdheim-Chester Disease and Other Histiocytoses

View source ↗

Summary

Memorial Sloan Kettering Cancer Center is recruiting participants for a registry study of Erdheim-Chester Disease and other histiocytoses (NCT03329274).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erdheim-chester Disease

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Erdheim-Chester Disease | Status: RECRUITING